- Home
- RRGB vs MNOV Comparison
RRGB vs MNOV Comparison
Compare RRGB & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- MNOV
- Stock Information
- Founded
- RRGB 1969
- MNOV 2000
- Country
- RRGB United States
- MNOV United States
- Employees
- RRGB N/A
- MNOV N/A
- Industry
- RRGB Restaurants
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- MNOV Health Care
- Exchange
- RRGB Nasdaq
- MNOV Nasdaq
- Market Cap
- RRGB 88.7M
- MNOV 68.2M
- IPO Year
- RRGB 2002
- MNOV 2005
- Fundamental
- Price
- RRGB $6.01
- MNOV $1.27
- Analyst Decision
- RRGB Strong Buy
- MNOV Strong Buy
- Analyst Count
- RRGB 4
- MNOV 2
- Target Price
- RRGB $11.88
- MNOV $7.00
- AVG Volume (30 Days)
- RRGB 374.7K
- MNOV 17.6K
- Earning Date
- RRGB 08-21-2025
- MNOV 08-07-2025
- Dividend Yield
- RRGB N/A
- MNOV N/A
- EPS Growth
- RRGB N/A
- MNOV N/A
- EPS
- RRGB N/A
- MNOV N/A
- Revenue
- RRGB $1,252,370,000.00
- MNOV N/A
- Revenue This Year
- RRGB N/A
- MNOV N/A
- Revenue Next Year
- RRGB N/A
- MNOV N/A
- P/E Ratio
- RRGB N/A
- MNOV N/A
- Revenue Growth
- RRGB N/A
- MNOV N/A
- 52 Week Low
- RRGB $2.50
- MNOV $1.12
- 52 Week High
- RRGB $7.05
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- RRGB 56.69
- MNOV 40.89
- Support Level
- RRGB $5.88
- MNOV $1.32
- Resistance Level
- RRGB $6.89
- MNOV $1.38
- Average True Range (ATR)
- RRGB 0.42
- MNOV 0.05
- MACD
- RRGB -0.05
- MNOV -0.00
- Stochastic Oscillator
- RRGB 61.14
- MNOV 15.38
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.